Showing results (51-60 of 110) with videos related to
Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2011
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patientsJ-Y Pierga, D Hajage, T Bachelot, et al.BMC Cancer|March 12, 2014
Ovarian cancer symptom awareness and anticipated delayed presentation in a population sampleKate E Brain, Stephanie Smits, Alice E Simon, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 4, 2015
Socioeconomic inequalities in attitudes towards cancer: an international cancer benchmarking partnership studySamantha L Quaife, Kelly Winstanley, Katie A Robb, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activityS Delaloge, A Yovine, A Taamma, et al.Gynecologic Oncology|September 5, 2012
Psychological outcomes of familial ovarian cancer screening: no evidence of long-term harmKate E Brain, Kate J Lifford, Lindsay Fraser, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2013
Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancerS T Ligthart, F-C Bidard, C Decraene, et al.Clinical Endocrinology|January 17, 2007
Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasiaLin Lin, Peter C Hindmarsh, Louise A Metherell, et al.British Journal of Cancer|January 1, 1997
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapyE Brain, C Garrino, J L Misset, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patientsA Yovine, M Riofrio, J Y Blay, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II studyI Monnet, Cremoux H de, P Soulié, et al.Pageof 11